Infectious Causation of Chronic Disease: Examining the Relationship Between Giardia Lamblia Infection and Irritable Bowel Syndrome

Overview

Journal World J Gastroenterol

Publisher Baishideng Publishing Group

Specialty Gastroenterology

Date 2007 Aug 31

PMID 17729408

Citations 5

Authors

Alice S Penrose

Eden V Wells

Allison E Aiello

Affiliations

Soon will be listed here.

Abstract

Aim: To evaluate whether a higher prevalence of Giardia lamblia infection is associated with an increase in irritable bowel syndrome (IBS) prescriptions at the county level in Michigan.

Methods: The Michigan Disease Surveillance System (MDSS) was used to ascertain both the numbers of Giardia lamblia infections as well as the total number of foodborne illnesses per population by county in Michigan during 2005. This was compared with Blue Cross Blue Shield (BCBS) of Michigan numbers of drug prescriptions for IBS per one thousand members per county in 2005. These data were also analyzed for associations with per capita income by county and the number of refugees entering each county in 2005.

Results: There were a total of 786 confirmed cases of Giardia lamblia reported to MDSS in 2005. During the same time period, the number of prescriptions for IBS varied from 0.5 per 1000 members up to 6.0 per 1000 members per month. There was no trend towards higher numbers of IBS prescriptions in the counties with more Giardia lamblia infections. Per capita income was not associated with either IBS prescriptions or Giardiasis. There was a significant linear association between the number of refugees entering each county, and the number of Giardia lamblia cases per 100,000 population.

Conclusion: In this ecological study, there was no association found between BCBS prescriptions for IBS and Giardia lamblia infections in Michigan counties. Our findings may have been influenced by the disparate number of refugees admitted per county.

Citing Articles

Pomegranate Peel Extract Is a Potential Alternative Therapeutic for Giardiasis.

El-Kady A, Abdel-Rahman I, Fouad S, Allemailem K, Istivan T, Ahmed S Antibiotics (Basel). 2021; 10(6).

PMID: 34208266 PMC: 8230894. DOI: 10.3390/antibiotics10060705.

First multilocus sequence typing (MLST) of Giardia duodenalis isolates from humans in Romania.

Costache C, Kalmar Z, Colosi H, Baciu A, Opris R, Gyorke A Parasit Vectors. 2020; 13(1):387.

PMID: 32736595 PMC: 7393877. DOI: 10.1186/s13071-020-04248-2.

Causal inference regarding infectious aetiology of chronic conditions: a systematic review.

Orrskog S, Medin E, Tsolova S, Semenza J PLoS One. 2013; 8(7):e68861.

PMID: 23935899 PMC: 3723854. DOI: 10.1371/journal.pone.0068861.

Comparison of methods for detection of Blastocystis infection in routinely submitted stool samples, and also in IBS/IBD Patients in Ankara, Turkey.

Dogruman-Al F, Simsek Z, Boorom K, Ekici E, Sahin M, Tuncer C PLoS One. 2010; 5(11):e15484.

PMID: 21124983 PMC: 2987810. DOI: 10.1371/journal.pone.0015484.

Development of functional gastrointestinal disorders after Giardia lamblia infection.

Hanevik K, Dizdar V, Langeland N, Hausken T BMC Gastroenterol. 2009; 9:27.

PMID: 19383162 PMC: 2676300. DOI: 10.1186/1471-230X-9-27.

References

Dear K, Elia M, Hunter J . Do interventions which reduce colonic bacterial fermentation improve symptoms of irritable bowel syndrome?. Dig Dis Sci. 2005; 50(4):758-66. DOI: 10.1007/s10620-005-2570-4. View

Ortega Y, Adam R . Giardia: overview and update. Clin Infect Dis. 1997; 25(3):545-9; quiz 550. DOI: 10.1086/513745. View

Hlavsa M, Watson J, Beach M . Giardiasis surveillance--United States, 1998-2002. MMWR Surveill Summ. 2005; 54(1):9-16. View

Marshall J, Thabane M, Garg A, Clark W, Salvadori M, Collins S . Incidence and epidemiology of irritable bowel syndrome after a large waterborne outbreak of bacterial dysentery. Gastroenterology. 2006; 131(2):445-50. DOI: 10.1053/j.gastro.2006.05.053. View

Grazioli B, Matera G, Laratta C, Schipani G, Guarnieri G, Spiniello E . Giardia lamblia infection in patients with irritable bowel syndrome and dyspepsia: a prospective study. World J Gastroenterol. 2006; 12(12):1941-4. PMC: 4087522. DOI: 10.3748/wjg.v12.i12.1941. View

Sinha P, Ghoshal U, Choudhuri G, Naik S, Ayyagari A, Naik S . Does Entamoeba histolytica cause irritable bowel syndrome?. Indian J Gastroenterol. 1997; 16(4):130-3. View

Hussain R, Jaferi W, Zuberi S, Baqai R, Abrar N, Ahmed A . Significantly increased IgG2 subclass antibody levels to Blastocystis hominis in patients with irritable bowel syndrome. Am J Trop Med Hyg. 1997; 56(3):301-6. DOI: 10.4269/ajtmh.1997.56.301. View

Bujanda L, Gutierrez-Stampa M, Caballeros C, Alkiza M . [Gastrointestinal disorders in Guatemala and their relation with parasitic infections]. An Med Interna. 2002; 19(4):179-82. View

Giacometti A, Cirioni O, Fiorentini A, Fortuna M, Scalise G . Irritable bowel syndrome in patients with Blastocystis hominis infection. Eur J Clin Microbiol Infect Dis. 1999; 18(6):436-9. DOI: 10.1007/s100960050314. View

10.

Lagace-Wiens P, VanCaeseele P, Koschik C . Dientamoeba fragilis: an emerging role in intestinal disease. CMAJ. 2006; 175(5):468-9. PMC: 1550747. DOI: 10.1503/cmaj.060265. View

11.

Yakoob J, Jafri W, Jafri N, Islam M, Beg M . In vitro susceptibility of Blastocystis hominis isolated from patients with irritable bowel syndrome. Br J Biomed Sci. 2004; 61(2):75-7. DOI: 10.1080/09674845.2004.11732647. View

12.

Carmona Sanchez R, Navarro Cano G . [Diagnostic value of limited research in patients with irritable bowel syndrome]. Rev Gastroenterol Mex. 2004; 69(1):24-9. View

13.

DAnchino M, Orlando D, De Feudis L . Giardia lamblia infections become clinically evident by eliciting symptoms of irritable bowel syndrome. J Infect. 2002; 45(3):169-72. DOI: 10.1016/s0163-4453(02)91038-8. View

14.

Kucik C, Martin G, Sortor B . Common intestinal parasites. Am Fam Physician. 2004; 69(5):1161-8. View

15.

Mearin F, Perez-Oliveras M, Perello A, Vinyet J, Ibanez A, Coderch J . Dyspepsia and irritable bowel syndrome after a Salmonella gastroenteritis outbreak: one-year follow-up cohort study. Gastroenterology. 2005; 129(1):98-104. DOI: 10.1053/j.gastro.2005.04.012. View

16.

Stermer E, Lubezky A, Potasman I, Paster E, Lavy A . Is traveler's diarrhea a significant risk factor for the development of irritable bowel syndrome? A prospective study. Clin Infect Dis. 2006; 43(7):898-901. DOI: 10.1086/507540. View

17.

Gomez-Escudero O, Schmulson-Wasserman M, Valdovinos-Diaz M . [Post-infectious irritable bowel syndrome. A review based on current evidence]. Rev Gastroenterol Mex. 2003; 68(1):55-61. View

18.

Stene L, Honeyman M, Hoffenberg E, Haas J, Sokol R, Emery L . Rotavirus infection frequency and risk of celiac disease autoimmunity in early childhood: a longitudinal study. Am J Gastroenterol. 2006; 101(10):2333-40. DOI: 10.1111/j.1572-0241.2006.00741.x. View

19.

Bolin T, Davis A, Duncombe V . A prospective study of persistent diarrhoea. Aust N Z J Med. 1982; 12(1):22-6. DOI: 10.1111/j.1445-5994.1982.tb02419.x. View

20.

Nayak A, Karnad D, Abraham P, Mistry F . Metronidazole relieves symptoms in irritable bowel syndrome: the confusion with so-called 'chronic amebiasis'. Indian J Gastroenterol. 1997; 16(4):137-9. View